New York company making at-home hormone test kits and a smartphone app for tracking fertility and perimenopause.
Founded in 2017 and headquartered in New York, US, OOVA, Inc. makes hormone monitoring products for women. Its Fertility Hormone Kit and Perimenopause Hormone Kit use urine test strips that are scanned with a smartphone app to report levels of LH, E3G and PdG. Revenue comes from kit sales and the OOVA Membership, which includes 1:1 consultations with hormone experts. The company completed a Series A round of USD 9.060 mn led by Spero Ventures, with investors including Jefferson Health, US Fertility and Virgin.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in